Is Taysha Gene Therapies, Inc. (TSHA) a Buy, Sell, or Hold?
Taysha Gene Therapies, Inc.
NASDAQ:TSHA
$5.7 USD
$0.32 (5.95%)
- Volume
- 4.26M
- Average Volume
- 3.11M
- Market Capitalization
- $1.43B
- P/E Ratio
- -14.89
- Dividend Yield
- 0.00%
- Price Target
- $14.50
- Year High
- $7.30
- Year Low
- $2.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.04
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-60.7% DOWNSIDE
$14.50 Price Target
UPSIDE/DOWNSIDE HIGH
-62.0% DOWNSIDE
$15.00 Price Target High
UPSIDE/DOWNSIDE LOW
-59.3% DOWNSIDE
$14.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Pivotal Research | Keith Tapper | $14 | $6.7299 | 2026-06-23 09:16 AM | 108.0% |
| Raymond James | Chris Raymond | $13 | $5.265 | 2026-01-06 10:31 AM | 146.9% |
| Wells Fargo | Zachary Fadem | $11 | $5.25 | 2026-01-05 07:37 AM | 109.5% |
| Cantor Fitzgerald | Kristen Kluska | $13 | $4.055 | 2025-11-14 07:26 AM | 220.6% |
| Robert W. Baird | Jack Allen | $12 | $4.765 | 2025-10-02 01:09 PM | 151.8% |
| Needham | Gil Blum | $10 | $4.765 | 2025-10-02 11:34 AM | 109.9% |